Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 20Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasm Malignant Female 1

Interventions

3-Iodobenzylguanidine 9Amifampridine 6nilotinib 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 5trametinib 4pembrolizumab 4gallium 68 PSMA-11 4fludarabine 4elotuzumab 4dabrafenib 4Nivolumab 4Bortezomib 4Afatinib 4venetoclax 3regorafenib 3midostaurin 3fludarabine phosphate 3TIC10 compound 3Sunitinib 3Prednisone 3Lenalidomide 3Ipilimumab 3Everolimus 3Dexamethasone 3Crizotinib 3Capecitabine 3Axitinib 3Alpelisib 3Abiraterone Acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × gedatolisib × Clear all
NCT05134922 2025-03-21

Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

Celcuity Inc

Available
Breast

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡